Learning health systems turn data into action — rapidly, safely, and continuously — so that innovation truly improves care.
Abstract: A novel CLL resonant converter with a semi-bridgeless active rectifier (S-BAR) is analyzed, and its hybrid control strategy is proposed in this paper. This topology is developed by replacing ...
The workflow encompasses patient datacollection and screening, univariate regression analysis for initial variable selection, systematic comparison of 91 machine learning models,selection and ...
Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...
"CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Pipeline"DelveInsight's,“CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2025,” report provides comprehensive insights ...
Wendtner has served on advisory boards for AbbVie, Amgen, Astrazeneca, BeOne Medicines, BIONTech, Cllag-Janssen, F. Hoffmann-La Roche, Genentech, Gilead, GSK ...
"Chronic Kidney Disease Pipeline Insights"DelveInsight's,“Chronic Kidney Disease - Pipeline Insight, 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Chronic ...
This report focuses on multiple aspects of predictive policing in the UK, including the systems themselves, the policing outcomes or decisions they influence, and the impact on individuals, groups and ...
Chronic lymphocytic leukemia (CLL) treatment options depend on your diagnosis. In earlier stages, “watchful waiting” may be recommended. More advanced CLL may require a combination of therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results